Within the last quarter, CinCor Pharma
CINC-1.72%+ Free Alerts
has observed the following analyst ratings:
|Bullish||Somewhat Bullish||Indifferent||Somewhat Bearish||Bearish|
In the last 3 months, 5 analysts have offered 12-month price targets for CinCor Pharma. The company has an average price target of $48.8 with a high of $73.00 and a low of $31.00.
This former hedge-fund trader is helping traders earn an additional income
Chris Capre is the real deal. With his simple options trading strategy, he’s helping thousands of traders by sharing his trade signals in real-time. Click Here to Get his Trades for only $1. ⭐⭐⭐⭐⭐ “My only regret is I wish I joined earlier…”
Below is a summary of how these 5 analysts rated CinCor Pharma over the past 3 months. The greater the number of bullish ratings, the more positive analysts are on the stock and the greater the number of bearish ratings, the more negative analysts are on the stock
This average price target has increased by 46.77% over the past month.
If you are interested in following small-cap stock news and performance you can start by tracking it here.
How Are Analyst Ratings Determined?
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish “analyst ratings” for stocks. Analysts typically rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.